Bevacizumab Exacerbates Paclitaxel-Induced Neuropathy: A Retrospective Cohort Study

• Ayumu Matsuoka ,

  * E-mail: ayumu0611@med.nagoya-u.ac.jp

  Affiliations Department of Clinical Oncology and Chemotherapy, Nagoya University Hospital, Nagoya, Japan, Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine, Nagoya, Japan

  ⨯
• Osamu Maeda,

  Affiliation Department of Clinical Oncology and Chemotherapy, Nagoya University Hospital, Nagoya, Japan

  ⨯
• Takefumi Mizutani,

  Affiliation Department of Clinical Oncology and Chemotherapy, Nagoya University Hospital, Nagoya, Japan

  ⨯
• Yasuyuki Nakano,

  Affiliation Department of Clinical Oncology, Japanese Red Cross Nagoya Daiichi Hospital, Nagoya, Japan

  ⨯
• Nobuyuki Tsunoda,

  Affiliation Division of Surgical Oncology, Department of Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan

  ⨯
• Toyone Kikumori,

  Affiliation Department of Breast and Endocrine Surgery, Nagoya University Hospital, Nagoya, Japan

  ⨯
• Hidemi Goto,

  Affiliation Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine, Nagoya, Japan

  ⨯
• Yuichi Ando

  Affiliation Department of Clinical Oncology and Chemotherapy, Nagoya University Hospital, Nagoya, Japan

  ⨯